Select Page

 

 

Infection and Global Health Research Division

Research at the University of St Andrews School of Medicine

 

research division icon

Respiratory infection

We have multiple areas of research in respiratory medicine covering tuberculosis pneumonia and bronchiectasis. Our researchers are keen to develop improved diagnostic pathways to support early recognition and then treatment of severe infection, drug development, and mathematical modelling of infection and treatment strategies. We also study molecular mechanisms of resistance, model systems to measure the fitness deficits found in drug resistant strains and investigate genomics of respiratory pathogens

Research staff

djd5

Dr Devesh Dhasmana

Respiratory infection; bronchiectasis; pneumonia; severe airways disease

shg3

Prof Stephen Gillespie

Tuberculosis; Clinical trials; Antibiotic resistance; MBLA; Scattered Light Integrated Collection (SLIC) 

djs26

Dr Derek Sloan

Senior Lecturer/Consultant in Infectious Diseases

ws31

Dr Wilber Sabiiti

Principal Research Fellow

Antimicrobial resistance

Progress in sequencing technology have meant that it is possible to capture and investigate the genetic diversity of the pathogen populations. This has opened up new possibilities for probing the biology and genetics of pathogens. Our group are interested in the relationship between a pathogen’s genotype and phenotype, in particular how the genetic makeup of an organism influences its virulence and resistance to antibiotics.

Research staff

mtgh

Prof Matthew Holden

Professor

Pathogen Genomics, Antibiotic Resistance, Hospital-Associated Infection, Bacterial Evolution, MRSA

afh22

Dr Andreas Haag

Lecturer

Hospital associated infections

The emergence and spread of bacterial pathogens that have become adapted for survival in hospitals poses a major threat to global health systems. One of the most prevalent organisms causing healthcare-associated infections is S. aureus. Clones of epidemic drug-resistant S. aureus have emerged.

The Holden group uses genomics to investigate the epidemiology and evolution of MRSA, from the global level right down to the patient level on the ward. Using phylogenetic and bioinformatic approaches we investigate the events surrounding the emergence and spread of successful clones of MRSA and the effect that antibiotics have had on shaping the pathogen population.

Research staff

Global Child Health

We are interested in the global influences on government revenue in low- and middle-income countries, and the impact this has on development and fundamental rights.

We try to quantify their impact in terms of access to fundamental rights (water, sanitation, education and healthcare), which are also Sustainable Development Goals, and the number of lives saved or lost. This project is called the Government Revenue and Development estimations, GRADE

Related

 

Research staff

bamo

Dr Bernadette O'Hare

Senior Lecturer

Global Health Equality; Fundamental Human Rights; The Right to Health; Children's Rights; Paediatrics; Child Health

mjl23

Dr Marisol Lopez

eah35

Dr Eilish Hannah

rmep1

Mrs Rachel Etter-Phoya

Ophthalmology

The ophthalmology research is performed in the United Kingdom as well as a number of lower resource settings with strong links in Rwanda, Malawi, Tanzania, India and Indonesia. Our aim is to reduce needless blindness, support sustainable growth of capacity, rehabilitate and positively influence policy.

The research programme covers a wide range of areas that include:

Research staff

ab312

Dr Andrew Blaikie

Senior Lecturer in Ophthalmology

Ophthalmology; Global Health; Early Diagnosis; Frugal Technology; Medical Education

frb2

Dr Frederick Burgess

wjw2

Mr William Williams

Innovation Fellow

ok32

Dr Obaid Kousha

Diagnostics and Innovations

Our research focuses on developing new diagnostic tools and medicines. So far, we have developed SLIC- a device which can test for the presence of bacteria in 10 minutes and thereafter for resistance in 30 minutes.  The Arclight is a low-cost diagnostic tool which can be used to screen for conditions in the eyes and ears.  MBLA is an assay originally specifically for TB infection but now being broadened to encompass a wider range of pathogens.

Research staff

ws31

Dr Wilber Sabiiti

Principal Research Fellow

rjhh

Dr Robert Hammond

Lecturer

Antimicrobial Resistance; Diagnostics; Tuberculosis; Dormancy; Optics

djs26

Dr Derek Sloan

Senior Lecturer/Consultant in Infectious Diseases

shg3

Prof Stephen Gillespie

Tuberculosis; Clinical trials; Antibiotic resistance; MBLA; Scattered Light Integrated Collection (SLIC)